• 24412 Citations
  • 83 Scopus h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination

Akhmetzyanova, I., McCarron, M. J., Parekh, S., Chesi, M., Bergsagel, P. L. & Fooksman, D. R., Jan 1 2020, In : Leukemia. 34, 1, p. 245-256 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Identification of PIKfyve kinase as a target in multiple myeloma

De Campos, C. B., Zhu, Y. X., Sepetov, N., Romanov, S., Bruins, L. A., Shi, C. X., Stein, C. K., Petit, J. L., Polito, A. N., Sharik, M. E., Meermeier, E. W., Ahmann, G. J., Armenta, I. D. L., Kruse, J., Bergsagel, P. L., Chesi, M., Meurice, N., Braggio, E. & Stewart, A. K., Jun 1 2020, In : Haematologica. 105, 6, p. 1641-1649 9 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

“Direct to Drug” screening as a precision medicine tool in multiple myeloma

Bonolo de Campos, C., Meurice, N., Petit, J. L., Polito, A. N., Zhu, Y. X., Wang, P., Bruins, L. A., Wang, X., Lopez Armenta, I. D., Darvish, S. A., Ahmann, G. J., Henderson, K. J., Tian, S., Kruse, J. J., Stewart, W. M., Larsen, J. T., Reeder, C. B., Dingli, D., Kapoor, P., Kumar, S. K. & 4 others, Fonseca, R., Bergsagel, P. L., Braggio, E. & Stewart, A. K., May 1 2020, In : Blood cancer journal. 10, 5, 54.

Research output: Contribution to journalArticle

Open Access
2019

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model

Guillerey, C., Nakamura, K., Pichler, A. C., Barkauskas, D., Krumeich, S., Stannard, K., Miles, K., Harjunpää, H., Yu, Y., Casey, M., Doban, A. I., Lazar, M., Hartel, G., Smith, D., Vuckovic, S., Teng, M. W. L., Leif Bergsagel, P., Chesi, M., Hill, G. R., Martinet, L. & 1 others, Smyth, M. J., Jul 25 2019, In : JCI Insight. 4, 14, :e125932.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

Zhu, Y. X., Shi, C. X., Bruins, L. A., Wang, X., Riggs, D. L., Porter, B., Ahmann, J. M., de Campos, C. B., Braggio, E. D., Bergsagel, P. L. & Stewart, A. K., Feb 1 2019, In : Blood cancer journal. 9, 2, 19.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma

Robinson, R. M., Reyes, L., Duncan, R. M., Bian, H., Reitz, A. B., Manevich, Y., McClure, J. J., Champion, M. M., Chou, C. J., Sharik, M. E., Chesi, M., Bergsagel, P. L. & Dolloff, N. G., Apr 1 2019, In : Leukemia. 33, 4, p. 1011-1022 12 p.

Research output: Contribution to journalArticle

4 Scopus citations

Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma

Smadbeck, J., Peterson, J. F., Pearce, K. E., Pitel, B. A., Figueroa, A. L., Timm, M., Jevremovic, A. D., Shi, M., Stewart, A. K., Braggio, E., Riggs, D. L., Bergsagel, P. L., Vasmatzis, G., Kearney, H. M., Hoppman, N. L., Ketterling, R. P., Kumar, S., Rajkumar, S. V., Greipp, P. T. & Baughn, L. B., Dec 1 2019, In : Blood cancer journal. 9, 12, 103.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

MiR-16 regulates crosstalk in NF-B tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages

Khalife, J., Ghose, J., Martella, M., Viola, D., Rocci, A., Troadec, E., Terrazas, C., Satoskar, A. R., Gunes, E. G., Dona, A., Sanchez, J. F., Leif Bergsagel, P., Chesi, M., Pozhitkov, A., Rosen, S., Marcucci, G., Keats, J. J., Hofmeister, C. C., Krishnan, A., Caserta, E. & 1 others, Pichiorri, F., Oct 8 2019, In : JCI Insight. 4, 21, e129348.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Thirukkumaran, C. M., Shi, Z. Q., Nuovo, G. J., Luider, J., Kopciuk, K. A., Dong, Y., Mostafa, A. A., Thakur, S., Gratton, K., Yang, A., Chin, A. C., Coffey, M. C., Jimenez-Zepeda, V. H., Stewart, D., Chesi, M., Bergsagel, P. L. & Morris, D., Mar 12 2019, In : Blood Advances. 3, 5, p. 797-812 16 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations
Open Access
2 Scopus citations

Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease

Liu, H., He, J., Koh, S. P., Zhong, Y., Liu, Z., Wang, Z., Zhang, Y., Li, Z., Tam, B. T., Lin, P., Xiao, M., Young, K. H., Amini, B., Starbuck, M. W., Lee, H. C., Navone, N. M., Davis, R. E., Tong, Q., Bergsagel, P. L., Hou, J. & 4 others, Yi, Q., Orlowski, R. Z., Gagel, R. F. & Yang, J., Jan 1 2019, In : Science translational medicine. 11, 494, eaau9087.

Research output: Contribution to journalArticle

5 Scopus citations
2018

Antigen-mediated regulation in monoclonal gammopathies and myeloma

Nair, S., Sng, J., Boddupalli, C. S., Seckinger, A., Chesi, M., Fulciniti, M., Zhang, L., Rauniyar, N., Lopez, M., Neparidze, N., Parker, T., Munshi, N. C., Sexton, R., Barlogie, B., Orlowski, R., Bergsagel, P. L., Hose, D., Flavell, R. A., Mistry, P. K., Meffre, E. & 1 others, Dhodapkar, M. V., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
12 Scopus citations

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression

Kawano, Y., Zavidij, O., Park, J., Moschetta, M., Kokubun, K., Mouhieddine, T. H., Manier, S., Mishima, Y., Murakami, N., Bustoros, M., Pistofidis, R. S., Reidy, M., Shen, Y. J., Rahmat, M., Lukyanchykov, P., Karreci, E. S., Tsukamoto, S., Shi, J., Takagi, S., Huynh, D. & 7 others, Sacco, A., Tai, Y. T., Chesi, M., Bergsagel, P. L., Roccaro, A. M., Azzi, J. & Ghobrial, I. M., Jun 1 2018, In : Journal of Clinical Investigation. 128, 6, p. 2487-2499 13 p.

Research output: Contribution to journalArticle

14 Scopus citations
12 Scopus citations

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment

Nakamura, K., Kassem, S., Cleynen, A., Chrétien, M. L., Guillerey, C., Putz, E. M., Bald, T., Förster, I., Vuckovic, S., Hill, G. R., Masters, S. L., Chesi, M., Bergsagel, P. L., Avet-Loiseau, H., Martinet, L. & Smyth, M. J., Jan 1 2018, (Accepted/In press) In : Cancer Cell.

Research output: Contribution to journalArticle

26 Scopus citations

Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients

González-Calle, V., Slack, A., Keane, N., Luft, S., Pearce, K. E., Ketterling, R. P., Jain, T., Chirackal, S., Reeder, C., Mikhael, J. R., Noel, P., Mayo, A., Adams, R. H., Ahmann, G., Braggio, E. D., Stewart, A. K., Bergsagel, P. L., van Wier, S. A. & Fonseca, R., Apr 6 2018, (Accepted/In press) In : Annals of Hematology. p. 1-10 10 p.

Research output: Contribution to journalArticle

6 Scopus citations

Importin-β and exportin-5 are strong biomarkers of productive reoviral infection of cancer cells

Nuovo, G., Tran, H., Gutierrez, A., Fadda, P., Pichiorri, F., Caserta, E., Hofmeister, C. C., Chesi, M., Bergsagel, P. L., Morris, D., Shi, Q., Coffey, M. & Thirukkumaran, C., Feb 1 2018, In : Annals of Diagnostic Pathology. 32, p. 28-34 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma

Bianchi-Smiraglia, A., Bagati, A., Fink, E. E., Affronti, H. C., Lipchick, B. C., Moparthy, S., Long, M. D., Rosario, S. R., Lightman, S. M., Moparthy, K., Wolff, D. W., Yun, D. H., Han, Z., Polechetti, A., Roll, M. V., Gitlin, I. I., Leonova, K. I., Rowsam, A. M., Kandel, E. S., Gudkov, A. V. & 4 others, Bergsagel, P. L., Lee, K. P., Smiraglia, D. J. & Nikiforov, M. A., Oct 1 2018, In : Journal of Clinical Investigation. 128, 10, p. 4682-4696 15 p.

Research output: Contribution to journalArticle

5 Scopus citations

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

Calcinotto, A., Brevi, A., Chesi, M., Ferrarese, R., Garcia Perez, L., Grioni, M., Kumar, S., Garbitt, V. M., Sharik, M. E., Henderson, K. J., Tonon, G., Tomura, M., Miwa, Y., Esplugues, E., Flavell, R. A., Huber, S., Canducci, F., Rajkumar, V. S., Bergsagel, P. L. & Bellone, M., Dec 1 2018, In : Nature communications. 9, 1, 4832.

Research output: Contribution to journalArticle

18 Scopus citations

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

Kumar, S. K., Buadi, F. K., LaPlant, B., Halvorson, A., Leung, N., Kapoor, P., Dingli, D. M., Gertz, M., Go, R. S., Bergsagel, P. L., Lin, Y., Dispenzieri, A., Hwa, Y. L., Fonder, A., Hobbs, M., Fonseca, R., Hayman, S. R., Stewart, A. K., Lust, J. A., Mikhael, J. R. & 5 others, Gonsalves, W., Reeder, C., Skacel, T., Rajkumar, S. V. & Lacy, M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 70.

Research output: Contribution to journalArticle

4 Scopus citations

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

9 Scopus citations
12 Scopus citations

Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

Jain, T., Kosiorek, H. E., Kung, S. T., Shah, V. S., Dueck, A., Gonzalez-Calle, V., Luft, S., Reeder, C. B., Adams, R., Noel, P., Larsen, J. T., Mikhael, J. R., Bergsagel, P. L., Stewart, A. K. & Fonseca, R., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

2 Scopus citations
2017

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

Ravi, P., Kumar, S. K., Gonsalves, W., Buadi, F., Lacy, M., Go, R. S., Dispenzieri, A., Kapoor, P., Lust, J. A., Dingli, D. M., Lin, Y., Russell, S. J., Leung, N., Gertz, M., Kyle, R. A., Bergsagel, P. L. & Rajkumar, S. V., Jun 16 2017, In : Blood Cancer Journal. 7, 6, p. e569

Research output: Contribution to journalArticle

3 Scopus citations
50 Scopus citations

Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity

Sebastian, S., Zhu, Y. X., Braggio, E. D., Shi, C. X., Panchabhai, S. C., Van Wier, S. A., Ahmann, G. J., Chesi, M., Bergsagel, P. L., Stewart, A. K. & Fonseca, R., Feb 23 2017, In : Blood. 129, 8, p. 991-1007 17 p.

Research output: Contribution to journalArticle

12 Scopus citations

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Pawlyn, C., Bright, M. D., Buros, A. F., Stein, C. K., Walters, Z., Aronson, L. I., Mirabella, F., Jones, J. R., Kaiser, M. F., Walker, B. A., Jackson, G. H., Clarke, P. A., Bergsagel, P. L., Workman, P., Chesi, M., Morgan, G. J. & Davies, F. E., Jan 1 2017, In : Blood Cancer Journal. 7, 3, e549.

Research output: Contribution to journalArticle

32 Scopus citations

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S., Gertz, M. A., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D., Go, R. S., Lin, Y., Gonsalves, W. I., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan-Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M. Q., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

López-Iglesias, A. A., Herrero, A. B., Chesi, M., San-Segundo, L., González-Méndez, L., Hernández-García, S., Misiewicz-Krzeminska, I., Quwaider, D., Martín-Sánchez, M., Primo, D., Paíno, T., Bergsagel, P. L., Mehrling, T., González-Díaz, M., San-Miguel, J. F., Mateos, M. V., Gutiérrez, N. C., Garayoa, M. & Ocio, E. M., Jun 20 2017, In : Journal of Hematology and Oncology. 10, 1, 127.

Research output: Contribution to journalArticle

12 Scopus citations

The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in models of multiple myeloma

Le Moigne, R., Aftab, B. T., Djakovic, S., Dhimolea, E., Valle, E., Murnane, M., King, E. M., Soriano, F., Menon, M. K., Wu, Z. Y., Wong, S. T., Lee, G. J., Yao, B., Wiita, A. P., Lam, C., Rice, J., Wang, J., Chesi, M., Bergsagel, P. L., Kraus, M. & 11 others, Driessen, C., Von Soly, S. K., Yakes, F. M., Wustrow, D., Shawver, L., Zhou, H. J., Martin, T. G., Wolf, J. L., Mitsiades, C. S., Anderson, D. J. & Rolfe, M., Nov 1 2017, In : Molecular Cancer Therapeutics. 16, 11, p. 2375-2386 12 p.

Research output: Contribution to journalArticle

30 Scopus citations

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

Stein, C. K., Pawlyn, C., Chavan, S., Rasche, L., Weinhold, N., Corken, A., Buros, A., Sonneveld, P., Jackson, G. H., Landgren, O., Mughal, T., He, J., Barlogie, B., Bergsagel, P. L., Davies, F. E., Walker, B. A. & Morgan, G. J., Jan 1 2017, In : Oncotarget. 8, 17, p. 27854-27867 14 p.

Research output: Contribution to journalArticle

11 Scopus citations
2016

Carfilzomib and the cardiorenal system in myeloma: An endothelial effect?

Rosenthal, A., Luthi, J., Belohlavek, M., Kortüm, K. M., Mookadam, F., Mayo, A., Fonseca, R., Bergsagel, P. L., Reeder, C. B., Mikhael, J. R. & Stewart, A. K., 2016, In : Blood Cancer Journal. 6, 1, e384.

Research output: Contribution to journalArticle

43 Scopus citations

Chromogranin a is preferentially cleaved into proangiogenic peptides in the bone marrow of multiple myeloma patients

Bianco, M., Gasparri, A. M., Colombo, B., Curnis, F., Girlanda, S., Ponzoni, M., Bertilaccio, M. T. S., Calcinotto, A., Sacchi, A., Ferrero, E., Ferrarini, M., Chesi, M., Bergsagel, P. L., Bellone, M., Tonon, G., Ciceri, F., Marcatti, M., Caligaris-Cappio, F. & Corti, A., Apr 1 2016, In : Cancer research. 76, 7, p. 1781-1791 11 p.

Research output: Contribution to journalArticle

14 Scopus citations

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

Ravi, P., Kumar, S. K., Larsen, J. T., Gonsalves, W., Buadi, F., Lacy, M., Go, R., Dispenzieri, A., Kapoor, P., Lust, J. A., Dingli, D. M., Lin, Y., Russell, S. J., Leung, N., Gertz, M., Kyle, R. A., Bergsagel, P. L. & Rajkumar, S. V., Jul 29 2016, In : Blood Cancer Journal. 6, 7, p. e454

Research output: Contribution to journalArticle

25 Scopus citations

Frequent occurrence of large duplications at reciprocal genomic rearrangement breakpoints in multiple myeloma and other tumors

Demchenko, Y., Roschke, A., Chen, W. D., Asmann, Y., Bergsagel, P. L. & Kuehl, W. M., Sep 30 2016, In : Nucleic Acids Research. 44, 17, p. 8189-8198 10 p.

Research output: Contribution to journalArticle

6 Scopus citations

IAP antagonists induce anti-tumor immunity in multiple myeloma

Chesi, M., Mirza, N. N., Garbitt, V. M., Sharik, M. E., Dueck, A., Asmann, Y., Akhmetzyanova, I., Kosiorek, H. E., Calcinotto, A., Riggs, D. L., Keane, N., Ahmann, G. J., Morrison, K. M., Fonseca, R., Lacy, M., Dingli, D. M., Kumar, S. K., Ailawadhi, S., Dispenzieri, A., Buadi, F. & 7 others, Gertz, M., Reeder, C. B., Lin, Y., Chanan Khan, A. A., Stewart, A. K., Fooksman, D. & Bergsagel, P. L., Dec 1 2016, In : Nature Medicine. 22, 12, p. 1411-1420 10 p.

Research output: Contribution to journalArticle

59 Scopus citations

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma

Bordini, J., Galvan, S., Ponzoni, M., Bertilaccio, M. T. S., Chesi, M., Bergsagel, P. L., Camaschella, C. & Campanella, A., Dec 13 2016, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

3 Scopus citations

Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients

Kortuem, K. M., Braggio, E. D., Bruins, L., Barrio, S., Shi, C. S., Zhu, Y. X., Tibes, R., Viswanatha, D., Votruba, P., Ahmann, G., Fonseca, R., Jedlowski, P., Schlam, I., Kumar, S. K., Bergsagel, P. L. & Stewart, A. K., 2016, In : Blood Cancer Journal. 6, 2, e397.

Research output: Contribution to journalArticle

31 Scopus citations

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., LaPlant, B. R., Reeder, C. B., Roy, V., Halvorson, A. E., Buadi, F., Gertz, M., Bergsagel, P. L., Dispenzieri, A., Thompson, M. A., Crawley, J., Kapoor, P., Mikhael, J. R., Stewart, A. K., Hayman, S. R., Hwa, Y. L., Gonsalves, W., Witzig, T. E., Ailawadhi, S., Dingli, D. M. & 5 others, Go, R. S., Lin, Y., Rivera, C. E., Rajkumar, S. V. & Lacy, M., Nov 17 2016, In : Blood. 128, 20, p. 2415-2422 8 p.

Research output: Contribution to journalArticle

30 Scopus citations

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

Kortüm, K. M., Mai, E. K., Hanafiah, N. H., Shi, C. X., Zhu, Y. X., Bruins, L., Barrio, S., Jedlowski, P., Merz, M., Xu, J., Stewart, R. A., Andrulis, M., Jauch, A., Hillengass, J., Goldschmidt, H., Bergsagel, P. L., Braggio, E., Stewart, A. K. & Raab, M. S., Sep 1 2016, In : Blood. 128, 9, p. 1226-1233 8 p.

Research output: Contribution to journalArticle

70 Scopus citations

Targeting vasculogenesis to prevent progression in multiple myeloma

Moschetta, M., Mishima, Y., Kawano, Y., Manier, S., Paiva, B., Palomera, L., Aljawai, Y., Calcinotto, A., Unitt, C., Sahin, I., Sacco, A., Glavey, S., Shi, J., Reagan, M. R., Prosper, F., Bellone, M., Chesi, M., Bergsagel, P. L., Vacca, A., Roccaro, A. M. & 1 others, Ghobrial, I. M., May 1 2016, In : Leukemia. 30, 5, p. 1103-1115 13 p.

Research output: Contribution to journalArticle

23 Scopus citations

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia

Boyiadzis, M., Bishop, M. R., Abonour, R., Anderson, K. C., Ansell, S. M., Avigan, D., Barbarotta, L., Barrett, A. J., Besien, K., Bergsagel, P. L., Borrello, I., Brody, J., Brufsky, J., Cairo, M., Chari, A., Cohen, A., Cortes, J., Forman, S. J., Friedberg, J. W., Fuchs, E. J. & 28 others, Gore, S. D., Jagannath, S., Kahl, B. S., Kline, J., Kochenderfer, J. N., Kwak, L. W., Levy, R., Lima, M., Litzow, M. R., Mahindra, A., Miller, J., Munshi, N. C., Orlowski, R. Z., Pagel, J. M., Porter, D. L., Russell, S. J., Schwartz, K., Shipp, M. A., Siegel, D., Stone, R. M., Tallman, M. S., Timmerman, J. M., Rhee, F., Waller, E. K., Welsh, A., Werner, M., Wiernik, P. H. & Dhodapkar, M. V., Dec 20 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 90.

Research output: Contribution to journalArticle

6 Scopus citations
2015

Advances in the pathogenesis and diagnosis of multiple myeloma

Chesi, M. & Bergsagel, P. L., May 1 2015, In : International Journal of Laboratory Hematology. 37, S1, p. 108-114 7 p.

Research output: Contribution to journalArticle

24 Scopus citations

Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy

Desantis, A., Bruno, T., Catena, V., De Nicola, F., Goeman, F., Iezzi, S., Sorino, C., Ponzoni, M., Bossi, G., Federico, V., La Rosa, F., Ricciardi, M. R., Lesma, E., De Meo, P. D. O., Castrignanò, T., Petrucci, M. T., Pisani, F., Chesi, M., Bergsagel, P. L., Floridi, A. & 4 others, Tonon, G., Passananti, C., Blandino, G. & Fanciulli, M., May 5 2015, In : EMBO Journal. 34, 9, p. 1214-1230 17 p.

Research output: Contribution to journalArticle

37 Scopus citations

Erratum: Immunosurveillance and therapy of multiple myeloma are CD226 dependent (Journal of Clinical Investigation (2015) 125:5 (2077-2089) DOI:10.1172/JCI77181)

Guillerey, C., De Andrade, L. F., Vuckovic, S., Miles, K., Ngiow, S. F., Yong, M. C. R., Teng, M. W. L., Colonna, M., Ritchie, D. S., Chesi, M., Bergsagel, P. L., Hill, G. R., Smyth, M. J. & Martinet, L., Jul 1 2015, In : Journal of Clinical Investigation. 125, 7, p. 2904 1 p.

Research output: Contribution to journalArticle

7 Scopus citations

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma

Bordini, J., Bertilaccio, M. T. S., Ponzoni, M., Fermo, I., Chesi, M., Bergsagel, P. L., Camaschella, C. & Campanella, A., 2015, In : Haematologica. 100, 6, p. 834-841 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

Guillerey, C., De Andrade, L. F., Vuckovic, S., Miles, K., Ngiow, S. F., Yong, M. C. R., Teng, M. W. L., Colonna, M., Ritchie, D. S., Chesi, M., Bergsagel, P. L., Hill, G. R., Smyth, M. J. & Martinet, L., May 1 2015, In : Journal of Clinical Investigation. 125, 5, p. 2077-2089 13 p.

Research output: Contribution to journalArticle

50 Scopus citations

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

Calcinotto, A., Ponzoni, M., Ria, R., Grioni, M., Cattaneo, E., Villa, I., Bertilaccio, M. T. S., Chesi, M., Rubinacci, A., Tonon, G., Bergsagel, P. L., Vacca, A. & Bellone, M., Jan 1 2015, In : OncoImmunology. 4, 6

Research output: Contribution to journalArticle

13 Scopus citations

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., Laplant, B., Roy, V., Reeder, C. B., Lacy, M., Gertz, M., Laumann, K., Thompson, M. A., Witzig, T. E., Buadi, F. K., Rivera, C. E., Mikhael, J. R., Bergsagel, P. L., Kapoor, P., Hwa, L., Fonseca, R., Stewart, A. K., Chanan Khan, A. A., Rajkumar, S. V. & Dispenzieri, A., Aug 14 2015, In : Blood Cancer Journal. 4, e338.

Research output: Contribution to journalArticle

50 Scopus citations